logo

MDXH

MDxHealth·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

MDXH fundamentals

MDxHealth (MDXH) released its earnings on Nov 12, 2025: revenue was 27.40M (YoY +17.51%), missed estimates; EPS was -0.16 (YoY +60.00%), missed estimates.
Revenue / YoY
27.40M
+17.51%
EPS / YoY
-0.16
+60.00%
Report date
Nov 12, 2025
MDXH Earnings Call Summary for Q3,2025
  • Revenue Growth: Q3 2025 revenue $27.4M (+18% YoY), driven by tissue-based tests (76% of revenue) and liquid-based growth (65% YoY).
  • ExoDx Acquisition: $20+M 2026 contribution expected, offsetting Germline de-emphasis.
  • Profitability: Gross margin 65.2% (vs 61.2% Q3 2024), positive EBITDA $1M.
  • Execution: 60 sales reps, seamless customer conversion to ExoDx, operational efficiency improvements.
EPS
Revenue

Revenue & Expenses

MDXH has released its 2025 Q3 earnings report, with revenue of 27.43M, reflecting a YoY change of 17.65%, and net profit of -8.01M, showing a YoY change of 28.41%. The Sankey diagram below clearly presents MDXH's revenue sources and cost distribution.

Key Indicators

MDxHealth (MDXH) key financial stats and ratios, covering profitability, financial health, and leverage.
MDxHealth (MDXH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
MDxHealth (MDXH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
MDxHealth (MDXH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does MDxHealth (MDXH) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track MDxHealth (MDXH) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield